ストックスクリーナーアプリを入手
5.75
5.89%
-0.36
プレマーケット:
5.81
0.06
+1.04%
前日終値:
$6.11
開ける：
$6.07
24時間の取引高:
44.87M
Relative Volume:
1.26
時価総額：
$2.46B
収益：
$64.60M
当期純損益:
$-377.75M
株価収益率:
-3.7097
EPS:
-1.55
ネットキャッシュフロー:
$-335.64M
1週間 パフォーマンス:
-15.32%
1か月 パフォーマンス:
+15.46%
6か月 パフォーマンス:
+2.13%
1年 パフォーマンス:
-13.01%
1日の値動き範囲:
$5.58
$6.31
1週間の範囲:
$5.58
$7.18
52週間の値動き範囲:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
名前
Recursion Pharmaceuticals Inc
セクター
電話
(385) 269-0203
住所
41S RIO GRANDE STREET, SALT LAKE CITY
RXRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
5.75 | 2.67B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.44 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.90 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.74 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
814.17 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
313.54 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-05-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-03-16 | 開始されました | Needham | Buy |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-04 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | 開始されました | Berenberg | Buy |
| 2021-05-11 | 開始されました | BofA Securities | Buy |
| 2021-05-11 | 開始されました | Goldman | Neutral |
| 2021-05-11 | 開始されました | JP Morgan | Neutral |
| 2021-05-11 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Recursion Pharmaceuticals Inc (RXRX) 最新ニュース
Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade) (NASDAQ:RXRX) - Seeking Alpha
Promising Biotech Stocks To ResearchOctober 19th - MarketBeat
When is the best time to exit Recursion Pharmaceuticals Inc.Breakout Watch & Weekly Chart Analysis and Guides - newser.com
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
Growth or Bubble? Decoding Recursion Pharmaceuticals Stock - StocksToTrade
Recursion Pharmaceuticals Stock: Growth or Bubble? - StocksToTrade
Top Biotech Stocks To Keep An Eye OnOctober 22nd - MarketBeat
Jim Cramer on Recursion Pharmaceuticals: “Now, It’s a Meme Stock” - Yahoo Finance
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com
Is it time to cut losses on Recursion Pharmaceuticals Inc.2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event - MSN
Has Recursion Pharmaceuticals Inc. formed a bullish divergenceTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Why RXRX’s Stock Came Tumbling Down? - timothysykes.com
What drives Recursion Pharmaceuticals Inc stock priceStock Price Divergence & Invest Like A Pro - earlytimes.in
RXRX Stock’s Unexpected Surge: Analyzing Future Trends - StocksToTrade
Top Biotech Stocks To ResearchOctober 21st - MarketBeat
Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings - Insider Monkey
Up 25% in 1 Month, Is This Stock a Buy? - AOL.com
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Navigating the Biotech Frontier with a 33.3% Revenue Surge - DirectorsTalk Interviews
How to recover losses in Recursion Pharmaceuticals Inc. stockForecast Cut & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-10-20 23:47:28 - newser.com
Will Recursion Pharmaceuticals Inc. stock recover faster than marketInflation Watch & Expert Approved Trade Ideas - newser.com
Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionDay Trade & Real-Time Stock Price Movement Reports - newser.com
Lightning Round: Recursion Pharma is now a meme stock, says Jim Cramer - MSN
Advanced analytics toolkit walkthrough for Recursion Pharmaceuticals Inc.July 2025 Volume & Smart Investment Allocation Insights - newser.com
Is Recursion Pharmaceuticals Set for Further Gains After Recent 36% Share Price Surge? - Yahoo Finance
Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? - Yahoo Finance
Recursion Pharmaceuticals (RXRX): Evaluating Valuation After AI Collaborations, Exscientia Deal, and Industry Leadership Moves - simplywall.st
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.Options Play & Expert-Curated Trade Recommendations - newser.com
Recursion Pharmaceuticals Inc. stock volume spike explainedWeekly Stock Analysis & Daily Stock Trend Reports - newser.com
Recursion Pharma Stock Soars 16% on AI Buzz and Big Pharma Deals – Can RXRX Keep Climbing? - ts2.tech
Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships - Quiver Quantitative
Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares - The Motley Fool
Why Recursion Pharmaceuticals Stock is Soaring - TipRanks
AI in Biotechnology Research Report 2025: An $11.4 Billion - GlobeNewswire
AI in Biotechnology Research Report 2025: An $11.4 Billion Market by 2030, Dominated by NVIDIA, Tempus AI, Recursion Pharmaceuticals, Schrodinger, and Sophia Genetics - Yahoo Finance
Recursion Pharmaceuticals call volume above normal and directionally bullish - TipRanks
10 Big Names Beating Wall Street at its Own Game - Insider Monkey
Will Recursion Pharmaceuticals Inc. stock maintain growth storyCEO Change & Daily Profit Maximizing Tips - newser.com
Recursion Pharmaceuticals Stock Analysis: Key Updates and Financial Overview - StocksToTrade
Recursion (RXRX) Gains After Acquiring Exscientia and Expanding AI Pharma Partnerships Has the Risk Profile Shifted? - simplywall.st
What analysts say about Recursion Pharmaceuticals Inc stockGeopolitical Risk Analysis & Small Budget Capital Gains - earlytimes.in
Is Recursion Pharmaceuticals Inc. stock a top momentum playJuly 2025 Fed Impact & Free Reliable Trade Execution Plans - nchmf.gov.vn
Market Moves: Is Recursion Pharmaceuticals Inc. stock a smart buy before Fed meetingJuly 2025 Setups & Safe Entry Trade Signal Reports - nchmf.gov.vn
Recursion Pharmaceuticals Hits Day High with 15.28% Surge in Stock Price - Markets Mojo
Great Week for Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Institutional Investors After Losing 2.9% Over the Previous Year - 富途牛牛
Is Recursion Pharmaceuticals a Millionaire Maker? - AOL.com
Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights - sharewise.com
Why Recursion Pharmaceuticals, Inc. (RXRX) Surged On Friday? - MSN
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals - ts2.tech
Recursion Pharmaceuticals Inc (RXRX) 財務データ
収益
当期純利益
現金流量
EPS
1.71%
0.87%
大文字化:
|
ボリューム (24 時間):